Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Study of K-645 in the Treatment of Multiple Migraine Attacks

NCT07116499 is registered in ClinicalTrials.gov with Kallyope Inc. as lead sponsor.

NCT NCT07116499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07116499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Study of K-645 in the Treatment of Multiple Migraine Attacks
Lead sponsor
Kallyope Inc.
Phase
Phase 2
Overall status
Terminated
Start date
August 12, 2025
Completion date
November 7, 2025
Enrollment
134 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acute migraine